Siddiqui Khan

SEC source: 0001209191-23-046313 · doc4.xml · nonDerivative · entry 1

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,981

F1 · price: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 29, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

SEC source: 0000899243-23-013890 · doc4.xml · derivative · entry 1

Siddiqui Khan · CIK 0001898560 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Class A Common Stock · 100,000 shares

Expires 2033-05-23

F1 · derivative.exercise_date: The shares underlying this option vest as to 25% of the shares on May 23, 2024, with the remainder vesting in 36 equal monthly installments thereafter, subject to Dr. Siddiqui's continued service through the applicable vesting date.

SEC source: 0001209191-23-029926 · doc4.xml · nonDerivative · entry 1

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,710

F1 · price: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 29, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

SEC source: 0001209191-23-023896 · doc4.xml · derivative · entry 1

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 368,400

Underlying: Class A Common Stock · 368,400 shares

Expires 2033-03-03

F1 · derivative.exercise_date: The shares underlying this option vest as to 25% of the shares on March 3, 2024, with the remainder vesting in 36 equal monthly installments thereafter, subject to Dr. Siddiqui's continued service through the applicable vesting date.

SEC source: 0001209191-23-010632 · doc4.xml · nonDerivative · entry 1

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,445

F1 · price: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 29, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

SEC source: 0001209191-22-057388 · doc4.xml · nonDerivative · entry 1

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,080

F1 · price: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 29, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

SEC source: 0001209191-22-055114 · doc4.xml · derivative · entry 10

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,000

Underlying: Class A Common Stock · 74,000 shares

Expires 2032-02-09

F5 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Dr. Siddiqui's continued service through the applicable vesting date.

F5 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Dr. Siddiqui's continued service through the applicable vesting date.

F5 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Dr. Siddiqui's continued service through the applicable vesting date.

SEC source: 0001209191-22-055114 · doc4.xml · derivative · entry 9

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 74,000 shares

Expires 2032-02-09

F5 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Dr. Siddiqui's continued service through the applicable vesting date.

F5 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Dr. Siddiqui's continued service through the applicable vesting date.

F5 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Dr. Siddiqui's continued service through the applicable vesting date.

SEC source: 0001209191-22-055114 · doc4.xml · derivative · entry 8

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,000

Underlying: Class A Common Stock · 110,000 shares

Expires 2032-02-09

F4 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 45,833 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F4 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 45,833 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F4 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 45,833 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

SEC source: 0001209191-22-055114 · doc4.xml · derivative · entry 7

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 110,000 shares

Expires 2032-02-09

F4 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 45,833 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F4 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 45,833 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F4 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 45,833 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

SEC source: 0001209191-22-055114 · doc4.xml · derivative · entry 6

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,796

Underlying: Class A Common Stock · 1,796 shares

Expires 2031-05-12

F3 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of whlich 636 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F3 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of whlich 636 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F3 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of whlich 636 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

SEC source: 0001209191-22-055114 · doc4.xml · derivative · entry 5

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 1,796 shares

Expires 2031-05-12

F3 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of whlich 636 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F3 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of whlich 636 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F3 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of whlich 636 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

SEC source: 0001209191-22-055114 · doc4.xml · derivative · entry 4

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,037

Underlying: Class A Common Stock · 54,037 shares

Expires 2031-04-14

F2 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 23,646 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F2 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 23,646 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F2 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 23,646 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

SEC source: 0001209191-22-055114 · doc4.xml · derivative · entry 3

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 54,037 shares

Expires 2031-04-14

F2 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 23,646 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F2 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 23,646 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F2 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 23,646 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

SEC source: 0001209191-22-055114 · doc4.xml · derivative · entry 2

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 235,145

Underlying: Class A Common Stock · 235,145 shares

Expires 2030-01-27

F1 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 161,657 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F1 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 161,657 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F1 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 161,657 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

SEC source: 0001209191-22-055114 · doc4.xml · derivative · entry 1

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 235,145 shares

Expires 2030-01-27

F1 · kind: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 161,657 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F1 · price: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 161,657 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

F1 · derivative.exercise_date: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 161,657 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date.

SEC source: 0001209191-22-046116 · doc4.xml · nonDerivative · entry 1

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,119

F1 · price: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 29, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

SEC source: 0001209191-22-041114 · doc4.xml · nonDerivative · entry 1

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,154

F1 · price: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 29, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

SEC source: 0001104659-22-041200 · tm2211004-3_4seq1.xml · nonDerivative · entry 2

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,000

F2 · shares: The shares underlying this RSU vest as to 25% on March 20, 2023, and the remainder in equal quarterly installments at the mid-point of each calendar quarter over the following three years, beginning on May 15, 2023, subject to Dr. Siddiqui's continued service through the applicable vesting date.

SEC source: 0001104659-22-041200 · tm2211004-3_4seq1.xml · nonDerivative · entry 1

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

F1 · shares: The shares underlying this restricted stock unit ("RSU") vest as to 25% on the grant date, and the remainder in equal quarterly installments at the mid-point of each calendar quarter over three years beginning February 15, 2021; provided that any vesting of the award will be delayed until July 1, 2022, and the number of RSUs vesting on the first scheduled vesting date following July 1, 2022 will also include any delayed vesting RSUs, subject to Dr. Siddiqui's continued service through the applicable vesting date.

SEC source: 0001104659-22-020844 · tm226447-3_4seq1.xml · derivative · entry 2

Siddiqui Khan · CIK 0001898560 · Chief Medical Officer and CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,000

Underlying: Class A Common Stock · 74,000 shares

Expires 2032-02-09

F2 · derivative.exercise_date: The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Dr. Siddiqui's continued service through the applicable vesting date.

SEC source: 0001104659-22-020844 · tm226447-3_4seq1.xml · derivative · entry 1

Siddiqui Khan · CIK 0001898560 · Chief Medical Officer and CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,000

Underlying: Class A Common Stock · 110,000 shares

Expires 2032-02-09

F1 · derivative.exercise_date: The shares underlying this option vest as to 25% on the date of grant, and 2.083% at the end of each month thereafter beginning on February 31, 2022, subject to Dr. Siddiqui's continued service through the applicable vesting date; provided that any vesting of the award will be delayed if as of the applicable vesting date a registration statement on Form S-8 registering shares under the registrant's 2021 Equity Incentive Plan has not yet been filed with the Securities and Exchange Commission, and in such event the number of options vesting on the first scheduled vesting date following the filing of the registration statement will also include any delayed vesting options.

SEC source: 0001104659-21-153338 · tm2135698d21_4seq1.xml · derivative · entry 4

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,796

Underlying: Class A Common Stock · 1,796 shares

Expires 2031-05-12

F9 · price: The shares underlying this option vest in forty eight equal monthly installments beginning on October 31, 2020, subject to Dr. Siddiqui's continued service through the applicable vesting date.

F8 · derivative.exercise_date: Received in connection with the Mergers in exchange for a stock option to acquire 10,000 shares of Liminal common stock for $0.94 per share.

SEC source: 0001104659-21-153338 · tm2135698d21_4seq1.xml · derivative · entry 3

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,037

Underlying: Class A Common Stock · 54,037 shares

Expires 2031-04-14

F7 · price: The shares underlying this option vest in forty eight equal monthly installments beginning on January 31, 2021, subject to Dr. Siddiqui's continued service through the applicable vesting date.

F6 · derivative.exercise_date: Received in connection with the Mergers in exchange for a stock option to acquire 165,000 shares of Hyperfine common stock for $1.23 per share.

SEC source: 0001104659-21-153338 · tm2135698d21_4seq1.xml · derivative · entry 2

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,345

Underlying: Class A Common Stock · 130,345 shares

Expires 2030-01-27

F5 · price: The shares underlying this option vested as to 25% on December 31, 2020, with the remainder of the options vesting in equal monthly installments, over the following three years, subject to Dr. Siddiqui's continued service on each vesting date.

F4 · derivative.exercise_date: Received in connection with the Mergers in exchange for a stock option to acquire 398,000 shares of Hyperfine common stock for $1.23 per share.

SEC source: 0001104659-21-153338 · tm2135698d21_4seq1.xml · derivative · entry 1

Siddiqui Khan · CIK 0001898560 · CMO and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,800

Underlying: Class A Common Stock · 104,800 shares

Expires 2030-01-27

F3 · price: The shares underlying this option vested as to 25% on December 31, 2020, with the remainder of the options vesting in equal monthly installments, over the following three years, subject to Dr. Siddiqui's continued service on each vesting date.

F1 · derivative.exercise_date: In connection with the closing of the transactions contemplated by the Business Combination Agreement, dated as of July 7, 2021, by and among HealthCor Catalio Acquisition Corp. ("HealthCor"), Optimus Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of HealthCor ("Merger Sub I"), Optimus Merger Sub II, Inc., a Delaware corporation and wholly owned subsidiary of HealthCor ("Merger Sub II"), Hyperfine, Inc., a Delaware corporation ("Hyperfine"), and Liminal Sciences, Inc., a Delaware corporation ("Liminal"), pursuant to which Merger Sub I merged with and into Hyperfine (the "Hyperfine Merger"), with Hyperfine surviving the Hyperfine Merger as a wholly owned subsidiary of HealthCor, and Merger Sub II merged with and into Liminal

F2 · derivative.exercise_date: (the "Liminal Merger" and, together with the Hyperfine Merger, the "Mergers"), with Liminal surviving the Liminal Merger as a wholly owned subsidiary of HealthCor (which changed its name to "Hyperfine, Inc.", the "Issuer"), these shares were received in connection with the Mergers in exchange for a stock option to acquire 320,000 shares of Hyperfine common stock for $1.23 per share.